<DOC>
	<DOCNO>NCT00143039</DOCNO>
	<brief_summary>The objective pilot study prospectively evaluate amniotic fluid pregnancy complicate non-immune hydrops severe symmetrical intrauterine growth restriction tandem mass spectrometry inborn error metabolism .</brief_summary>
	<brief_title>Amniotic Fluid Tandem Mass Spectrometry Pregnancies Complicated NIH Severe Symmetrical IUGR</brief_title>
	<detailed_description>Nonimmune hydrops ( NIH ) severe symmetrical intrauterine growth restriction ( IUGR ) represent two obstetrical circumstance occur relative frequency yet often escape adequate etiology assessment diagnosis prior birth . Both condition high perinatal neonatal mortality rate . While antepartum ultrasound amniotic fluid evaluation fetal karyotype viral DNA study diagnose etiology NIH severe symmetrical IUGR , large percentage NIH ( 30-40 % ) IUGR ( 20-30 % ) case attribute idiopathic cause . Because uncertainty diagnosis , many case subject prolonged antepartum hospitalization intensive fetal monitoring urgent delivery Cesarean section non-reassuring fetal status , succumb neonatal demise nursery . A small percentage ( 1-2 % ) case find due inborn error metabolism neonatal and/or postmortem evaluation ; however , combine together , great 50 % NIH IUGR case identifiable etiology . Therefore , new test may make diagnosis NIH severe symmetrical IUGR prior delivery would extremely important management mother infant . Tandem mass spectrometry inborn error metabolism may represent new tool assessing , identify , treat currently unexplained case NIH severe symmetrical IUGR . This prospective pilot cohort study pregnancy complicate NIH severe symmetrical IUGR within Pediatrix-Obstetrix network . This network encompass several perinatal site throughout United States correspond neonatal intensive care unit utilize computerized patient database ( RDS ) . The objective study prospectively evaluate amniotic fluid pregnancy complicate NIH severe symmetrical IUGR method call tandem mass spectrometry inborn error metabolism .</detailed_description>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Hydrops Fetalis</mesh_term>
	<criteria>NIH Singleton gestation 18 year age old Excess extracellular fluid least two fetal site note ultrasound : abdomen ( ascites ) , chest ( pleural pericardial effusion ) , skin ( edema &gt; 5mm ) , amniotic cavity ( polyhydramnios ) , placenta ( thicken &gt; 6cm ) NIH diagnosis &gt; 15w0d gestation Diagnostic amniocentesis perform &gt; 15w0d gestation NIH Immunemediated hydrops fetalis diagnose maternal red cell antigens fetal anemia suspect middle cerebral artery doppler ultrasound and/or confirm percutaneous umbilical blood sample Structural anomaly identify ultrasound Chromosomal aneuploidy Multiple gestation IUGR Singleton gestation 18 year age old Severe symmetrical IUGR define &gt; 3 week lag fetal ultrasound measurement ( biparietal diameter , head circumference , abdominal circumference , femur length ) IUGR diagnosis 2432 week gestation Diagnostic amniocentesis perform prior 32 week gestation IUGR Asymmetrical IUGR Structural anomaly identify ultrasound Chromosomal aneuploidy Multiple gestation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>NIH</keyword>
	<keyword>Severe Symmetrical IUGR</keyword>
	<keyword>Tandem Mass Spectrometry</keyword>
	<keyword>Nonimmune Hydrops</keyword>
	<keyword>Severe Symmetrical Intrauterine Growth Restriction</keyword>
</DOC>